- Nicholas T. Bello. Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesity. Expert Opinion on Drug Safety 2019. DOI
- Ward TL, Dominguez-Bello MG, Heisel T, Al-Ghalith G, Knights D, Gale CA. Development of the human mycobiome over the first month of life and across body sites. mSystems 2018, 3 (3): e00140-17.
- Fragiadakis GK, Smits SA, Sonnenburg ED, Van Treuren W, Reid G, Knight R, Manjurano A, Changalucha J, Dominguez-Bello MG, Leach J, Sonnenburg JL. Links between environment, diet, and the hunter-gatherer microbiome. bioRxiv 2018: 319673. DOI
- Debelius JW, McDonald D, Ackermann G, Fahimpour AK, Gilbert JA, Green JL, Gonzalez A, Huttenhower C, Hyde E, Kelley ST, DKnights, Ladau J, Morgan X, Navas-Molina J, Montassier E, Rahnavard G, Pollard KS, Sangwan N, Shorenstein J, Thompson L, Thackray V, Wischmeyer P, The American Gut Consortium, Knight R. American Gut: an Open Platform for Citizen-Science Microbiome Research. mSystems 2018, 3(3): e00031-18. DOI
- Ruggles KV, Wang J, Volkova A, Contreras M, Noya-Alarcon O, Lander O, Caballero H, Dominguez-Bello MG. Changes in the gut microbiota of urban subjects during an immersion in the traditional diet and lifestyle of a rainforest village. mSphere 2018, 3(4): e00193-18. DOI.
- Siqueira J, Dominguez-Bello M, Contreras M, Lander O, Caballero-Arias H, Deng X, Noya-Alarcon, O and Delwart E. Complex virome in feces from Amerindian children in isolated Amazonian villages. Nature Communications, 2018, 9:4270. DOI
- Dominguez-Bello MG, Knight R, Gilbert JA, Blaser MJ. Restoring microbial diversity, an ancestral legacy for future generations. Science 2018, 362(6410): 33-34. DOI
- Combellick JL, Shin H, Shin D, Cai Y, Hagan H, Lacher C, Lin DL, McCauley K, Lynch S, Dominguez-Bello MG. Differences in the fecal microbiota of neonates born at home or in the hospital. Sci Reports 2018, 8:15660. DOI
- Dominguez Bello MG. Effects of C-section on the human microbiota. Am J Hum Biol. 2018; e23196. DOI
- PeBenito A, Nazzal L, Huan C, Li H, Jay M, Noya-Alarcon O, Contraras M, Lander O, Leach J, Dominguez-Bello MG, Blaser MJ. Comparative prevalence of Oxalobacter formigenes in three human populations. Sci Rep 2019, 9:574 DOI
- V. Vartanian, J. Tumova, P. Dobrzyn, A. Dobrzyn, Y. Nakabeppu, R.S. Lloyd, and H. Sampath. 2017. 8-oxoguanine DNA glycosylase (OGG1) deficiency elicits coordinated changes in lipid and mitochondrial metabolism in muscle. PLoS ONE 12(7): e0181687.
- L. Zhao, Feng Zhang, Xiaoying Ding, Guojun Wu, Yan Y. Lam, et. al. (2018) Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes Science 359, 1151-1156.
- Zhang C., the MetaGUT Consortium, Zhao L. Dietary modulation of gut microbiota contributes to alleviation of both genetic and simple obesity in children. EBioMedicine, 2015, DOI
- Fei N. and Zhao L. An opportunistic pathogen from the gut of an obese human causes obesity in germfree mice. ISME J 2013, 7(4): 880–884
- Xiao S., Fei N., Pang X., Shen J., Wang L., Zhang B., Zhang M., Zhang X., Zhang C., Li M., Sun, L., Xue Z., Wang J., Feng J., Yan F., Zhao N., Liu J., Long W. and Zhao L. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol 2013, DOI
- Zhang C., Zhang M., Wang S., Han R., Cao Y., Hua W., Mao Y., Zhang X., Pang X., Wei C., Zhao G., Chen Y. and Zhao L. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 2010, 4(2): 232-241
- Zhang C., Zhang M., Pang X., Zhao Y., Wang L. and Zhao L. Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J 2012, 6(10): 1848-1857
- Zhang C., Li S., Yang L., Huang P., Li W., Wang S., Zhao G., Zhang M., Pang X., Yan Z., Liu Y. and Zhao L. Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat Commun 2013, 4: 2163
- Zhao L. The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol 2013, 11(9): 639-647 (Review)
- Zhang M., Zhang M., Zhang C., Du H., Wei G., Pang X., Zhou H., Liu B. and Zhao L. Pattern extraction of structural responses of gut microbiota to rotavirus infection via multivariate statistical analysis of clone library data. FEMS Microbiol Ecol 2009, 70(2): 21-29.
- Zhang C., Zhang M., Wang S., Han R., Cao Y., Hua W., Mao Y., Zhang X., Pang X., Wei C., Zhao G., Chen Y. and Zhao L. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 2010, 4(2): 232-241
- Li M., Wang B., Zhang M., Rantalainen M., Wang S., Zhou H., Zhang Y., Shen J., Pang X., Zhang M,. Wei H., Chen Y., Lu H., Zuo J., Su M., Qiu Y., Jia W., Xiao C., Smith L.M., Yang S., Holmes E., Tang H., Zhao G., Nicholson J.K., Li L. and Zhao L. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 2008, 105(6): 2117-2122.
- Zhang C., the MetaGUT Consortium, Zhao L., Dietary modulation of gut microbiota contributes to alleviation of both genetic and simple obesity in children. EBioMedicine, 2015, DOI
- Zhang X., Zhao Y., Zhang M., Pang X., Xu J., Kang C., Li M., Zhang C., Zhang Z., Zhang Y., Li X., Ning G. and Zhao L. Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats. PLoS One 2012, 7(8): e42529.
- Xu J, Lian F., Zhao L., Zhao Y., Zhao L., and Tong X. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. ISME J 2014. DOI.
- Tong,X. J. Xu, F. Lian, X. Yu, Y. Zhao, L. Xu, M. Zhang, X. Zhao, J. Shen, S. Wu, X. Pang, J. Tian, C. Zhang, Q. Zhou, L. Wang, B. Pang, F. Chen, Z. Peng, J. Wang, Z. Zhen, C. Fang, M. Li, L. Chen, L. Zhao. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial mBio 9 (3), e02392-17
